Tehran, May 28, IRNA - Iranian research company, Ariatinagen, has produced a medicine named Tinagrast for cancer patients undergoing chemotherapy. Navid Mirqasemi, manager of the company, said Tinagrast helps patients overcome neutropenia and infections. Neutropenia is a granulocyte disorder characterized by an abnormally low number of neutrophils....